Early trial tests new Drug's effect on fatty liver disease
NCT ID NCT06104319
Summary
This early-stage study tested a single dose of an experimental drug, GSK4532990, in 61 adults with non-alcoholic steatohepatitis (NASH), a type of fatty liver disease. The main goals were to see how the body processes the drug, how it affects the liver, and to check its safety. Researchers measured changes in specific liver proteins and genetic material from biopsies taken before and after the dose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Chula Vista, California, 91911, United States
-
GSK Investigational Site
Montclair, California, 91763, United States
-
GSK Investigational Site
San Diego, California, 91911, United States
-
GSK Investigational Site
San Diego, California, 91942, United States
-
GSK Investigational Site
Brandon, Florida, 33511, United States
-
GSK Investigational Site
Miami, Florida, 33155, United States
-
GSK Investigational Site
Miami, Florida, 33173, United States
-
GSK Investigational Site
Miami Lakes, Florida, 33014, United States
-
GSK Investigational Site
Indianapolis, Indiana, 46202, United States
-
GSK Investigational Site
El Dorado, Kansas, 67042, United States
-
GSK Investigational Site
Marrero, Louisiana, 70072, United States
-
GSK Investigational Site
Austin, Texas, 78745, United States
-
GSK Investigational Site
San Antonio, Texas, 78215, United States
-
GSK Investigational Site
San Antonio, Texas, 78240, United States
Conditions
Explore the condition pages connected to this study.